The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




AstraZeneca PLC - AZN Enhertu US orphan designation in gastric cancer
07:00 22-May-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN AstraZeneca advances response to COVID-19 outbreak
07:00 21-May-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Lynparza approved in the US for prostate cancer
07:00 20-May-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Bevespi Aerosphere approved in China for COPD
07:00 18-May-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Enhertu US Breakthrough status for lung cancer
07:00 18-May-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Brazikumab rights recovered by AstraZeneca
07:00 11-May-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Lynparza gets broader US ovarian cancer approval
07:00 11-May-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Enhertu designated gastric cancer BTD
07:00 11-May-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Farxiga approved by FDA for heart failure (HFrEF)
07:00 06-May-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Result of AGM
16:00 29-Apr-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN AZN: first-quarter 2020 results
07:00 29-Apr-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Lynparza shows overall survival in prostate cancer
07:00 24-Apr-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Changes to arrangements for AGM
11:00 17-Apr-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Tagrisso adjuvant trial overwhelmingly positive
07:00 14-Apr-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Koselugo (selumetinib) approved in the US for NF1
07:00 14-Apr-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN AstraZeneca divestment of Movantik completed
07:00 02-Apr-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Imfinzi approved in US for small cell lung cancer
07:01 30-Mar-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Farxiga CKD trial early stop for positive efficacy
07:00 30-Mar-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Lokelma approved in Japan for hyperkalaemia
07:00 26-Mar-2020  RNS  4.21% View chart
AstraZeneca PLC - AZN Second Price Monitoring Extn
16:41 24-Mar-2020  RNS  4.21% View chart

 Page 1 of 2

| 1 | 2 | Next



RNS - regulatory news service - home


MARKET NEWS – SEARCH FEATURES

Market News is the definitive place to view real-time UK regulatory disclosures.

You will see a clear and comprehensive search, filter and sort features giving users the ability to:

  • Show only Earnings and News announcements - the default search
  • Show all announcements excluding NAVs & FRNs
  • Show all announcement types
  • See up to 500 stories per page
  • See ‘Most read news’ ticker at the top of the page
  • Select stories by Name/code, source, type, index or sector


about rns

 

News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds